{
    "startDate": "2018-01-01",
    "endDate": "2018-03-31",
    "year": "2018",
    "quarter": "Q1",
    "symbol": "ADRO",
    "data": {
        "bs": [
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 100279000
            },
            {
                "label": "Short-term marketable securities",
                "concept": "MarketableSecuritiesCurrent",
                "unit": "usd",
                "value": 207029000
            },
            {
                "label": "Accounts receivable",
                "concept": "AccountsReceivableNetCurrent",
                "unit": "usd",
                "value": 702000
            },
            {
                "label": "Income tax receivable",
                "concept": "IncomeTaxReceivable",
                "unit": "usd",
                "value": 17495000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 5309000
            },
            {
                "label": "Current assets:",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 330814000
            },
            {
                "label": "Long-term marketable securities",
                "concept": "MarketableSecuritiesNoncurrent",
                "unit": "usd",
                "value": 20541000
            },
            {
                "label": "Property and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 30168000
            },
            {
                "label": "Goodwill",
                "concept": "Goodwill",
                "unit": "usd",
                "value": 8972000
            },
            {
                "label": "Intangible assets, net",
                "concept": "IntangibleAssetsNetExcludingGoodwill",
                "unit": "usd",
                "value": 31843000
            },
            {
                "label": "Restricted cash",
                "concept": "RestrictedCashNoncurrent",
                "unit": "usd",
                "value": 468000
            },
            {
                "label": "Assets",
                "concept": "Assets",
                "unit": "usd",
                "value": 422806000
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 1847000
            },
            {
                "label": "Amount of obligations incurred and payable, pertaining to costs that are statutory in nature, incurred in relation to clinical trials and product manufacturing expenses, or accumulate over time and for which invoices have not yet been received or will not be rendered.",
                "concept": "adro:AccruedClinicalTrialAndManufacturingExpensesCurrent",
                "unit": "usd",
                "value": 3876000
            },
            {
                "label": "Accrued expenses and other liabilities",
                "concept": "AccruedLiabilitiesAndOtherLiabilities",
                "unit": "usd",
                "value": 8569000
            },
            {
                "label": "Contingent consideration",
                "concept": "BusinessCombinationContingentConsiderationLiabilityCurrent",
                "unit": "usd",
                "value": 7172000
            },
            {
                "label": "Deferred revenue",
                "concept": "DeferredRevenueCurrent",
                "unit": "usd",
                "value": 14882000
            },
            {
                "label": "Current liabilities:",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 36346000
            },
            {
                "label": "Deferred rent",
                "concept": "DeferredRentCreditNoncurrent",
                "unit": "usd",
                "value": 11109000
            },
            {
                "label": "Contingent consideration",
                "concept": "BusinessCombinationContingentConsiderationLiabilityNoncurrent",
                "unit": "usd",
                "value": 999000
            },
            {
                "label": "Deferred revenue",
                "concept": "DeferredRevenueNoncurrent",
                "unit": "usd",
                "value": 169857000
            },
            {
                "label": "Deferred tax liabilities",
                "concept": "DeferredTaxLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 6704000
            },
            {
                "label": "Other long-term liabilities",
                "concept": "OtherLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 832000
            },
            {
                "label": "Liabilities and Stockholders\u2019 Equity",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 225847000
            },
            {
                "label": "Commitments and contingencies (Note 7)",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Preferred stock, $0.0001 par value; 10,000,000 shares authorized; and zero shares issued and outstanding at March 31, 2018 and December 31, 2017",
                "concept": "PreferredStockValue",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Common stock, $0.0001 par value; 300,000,000 shares authorized; and 78,478,666 and 77,736,201 shares issued and outstanding at March 31, 2018 and December 31, 2017",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 8000
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapitalCommonStock",
                "unit": "usd",
                "value": 524997000
            },
            {
                "label": "Accumulated other comprehensive income",
                "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": 2621000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -330667000
            },
            {
                "label": "Stockholders\u2019 equity:",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 196959000
            },
            {
                "label": "Liabilities and Stockholders\u2019 Equity",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 422806000
            }
        ],
        "cf": [
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -21494000
            },
            {
                "label": "Depreciation and amortization",
                "concept": "DepreciationAndAmortization",
                "unit": "usd",
                "value": 1078000
            },
            {
                "label": "Amortization of intangible assets",
                "concept": "AmortizationOfIntangibleAssets",
                "unit": "usd",
                "value": 152000
            },
            {
                "label": "Accretion of discounts and amortization of premiums on marketable securities",
                "concept": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
                "unit": "usd",
                "value": 213000
            },
            {
                "label": "Stock-based compensation",
                "concept": "AllocatedShareBasedCompensationExpense",
                "unit": "usd",
                "value": 4924000
            },
            {
                "label": "Loss from remeasurement of fair value of contingent consideration",
                "concept": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
                "unit": "usd",
                "value": 365000
            },
            {
                "label": "Loss on disposal of property and equipment",
                "concept": "GainLossOnSaleOfPropertyPlantEquipment",
                "unit": "usd",
                "value": -4000
            },
            {
                "label": "Deferred income tax",
                "concept": "DeferredIncomeTaxesAndTaxCredits",
                "unit": "usd",
                "value": -21000
            },
            {
                "label": "Accounts receivable",
                "concept": "IncreaseDecreaseInAccountsReceivable",
                "unit": "usd",
                "value": -288000
            },
            {
                "label": "Prepaid expenses and other assets",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": -265000
            },
            {
                "label": "Accounts payable",
                "concept": "IncreaseDecreaseInAccountsPayable",
                "unit": "usd",
                "value": 679000
            },
            {
                "label": "Deferred revenue",
                "concept": "IncreaseDecreaseInDeferredRevenue",
                "unit": "usd",
                "value": -3644000
            },
            {
                "label": "The increase (decrease) during the reporting period in the aggregate amount of accrued clinical trial and manufacturing expenses not separately disclosed in the statement of cash flows.",
                "concept": "adro:IncreaseDecreaseAccruedClinicalTrialAndManufacturingExpenses",
                "unit": "usd",
                "value": -2075000
            },
            {
                "label": "Accrued expenses and other liabilities",
                "concept": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities",
                "unit": "usd",
                "value": -909000
            },
            {
                "label": "Cash Flows from Operating Activities",
                "concept": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
                "unit": "usd",
                "value": -20601000
            },
            {
                "label": "Purchase of marketable securities",
                "concept": "PaymentsToAcquireMarketableSecurities",
                "unit": "usd",
                "value": 121152000
            },
            {
                "label": "Proceeds from maturities of marketable securities",
                "concept": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
                "unit": "usd",
                "value": 85749000
            },
            {
                "label": "Purchase of property and equipment",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 2119000
            },
            {
                "label": "Cash Flows from Investing Activities",
                "concept": "NetCashProvidedByUsedInInvestingActivitiesContinuingOperations",
                "unit": "usd",
                "value": -37522000
            },
            {
                "label": "Proceeds from exercise of stock options and warrants",
                "concept": "ProceedsFromStockOptionsExercised",
                "unit": "usd",
                "value": 617000
            },
            {
                "label": "Cash Flows from Financing Activities",
                "concept": "NetCashProvidedByUsedInFinancingActivitiesContinuingOperations",
                "unit": "usd",
                "value": 617000
            },
            {
                "label": "Effect of exchange rate changes",
                "concept": "EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations",
                "unit": "usd",
                "value": 171000
            },
            {
                "label": "Net (decrease) increase in cash, cash equivalents, and restricted cash",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                "unit": "usd",
                "value": -57335000
            },
            {
                "label": "Purchase of property and equipment in accounts payable and accrued liabilities",
                "concept": "CapitalExpendituresIncurredButNotYetPaid",
                "unit": "usd",
                "value": 781000
            }
        ],
        "ic": [
            {
                "label": "Collaboration and license revenue",
                "concept": "LicenseAndServicesRevenue",
                "unit": "usd",
                "value": 6627000
            },
            {
                "label": "Revenue:",
                "concept": "Revenues",
                "unit": "usd",
                "value": 6627000
            },
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 20128000
            },
            {
                "label": "General and administrative",
                "concept": "GeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 9045000
            },
            {
                "label": "Amortization of intangible assets",
                "concept": "AmortizationOfIntangibleAssets",
                "unit": "usd",
                "value": 152000
            },
            {
                "label": "Operating expenses:",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 29325000
            },
            {
                "label": "Loss from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -22698000
            },
            {
                "label": "Interest income",
                "concept": "InvestmentIncomeInterest",
                "unit": "usd",
                "value": 1199000
            },
            {
                "label": "Other loss, net",
                "concept": "OtherNonoperatingIncomeExpense",
                "unit": "usd",
                "value": -16000
            },
            {
                "label": "Loss before income tax",
                "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
                "unit": "usd",
                "value": -21515000
            },
            {
                "label": "Income tax benefit",
                "concept": "IncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": -21000
            },
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -21494000
            },
            {
                "label": "Net loss per common share, basic and diluted",
                "concept": "EarningsPerShareBasicAndDiluted",
                "unit": "usd/shares",
                "value": -0.28
            },
            {
                "label": "Shares used in computing net loss per common share, basic and diluted",
                "concept": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "unit": "shares",
                "value": 77906645
            },
            {
                "label": "Unrealized loss on marketable securities",
                "concept": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
                "unit": "usd",
                "value": -149000
            },
            {
                "label": "Foreign currency translation adjustments",
                "concept": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
                "unit": "usd",
                "value": 877000
            },
            {
                "label": "Comprehensive loss",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": -20766000
            }
        ]
    }
}